SECONDARY AMYLOIDOSIS IN LEPROSY
Authors: J S SHUTTLEWORTH,  SISTER HILARY ROSS
Journal: Annals of Internal Medicine (1956)

Article1 July 1956SECONDARY AMYLOIDOSIS IN LEPROSYJOHN S. SHUTTLEWORTH, M.D., HILARY ROSS, B.S.JOHN S. SHUTTLEWORTH, M.D., HILARY ROSS, B.S.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-45-1-23 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptIn the National Leprosarium of the United States the leading cause of death in leprosy is secondary amyloidosis. The amyloidosis has been associated only with lepromatous disease, but has not been limited to cases of advanced disease or to cases showing extensive ulcerative processes. It may be seen in relatively young people who have had active lepromatous leprosy for only a few years or who have had leprosy of longer duration, but show minimal changes except for positive skin scrapings forMycobacterium leprae. Amyloidosis may also occur in cases of longer duration which have been aggravated by chronic secondary infections,...Bibliography1. Wolcott RR: Erythema nodosum in leprosy, Internat. J. Leprosy 15: 380-388, 1947. MedlineGoogle Scholar2. Mathews WH: Primary systemic amyloidosis, Am. J. M. Sc. 228: 317-333, 1954. CrossrefMedlineGoogle Scholar3. JonesFrazier RSDB: Primary cardiovascular amyloidosis; its clinical manifestations, pathology and histogenesis, Arch. Path. 50: 366-384, 1950. Google Scholar4. KoletskyStecher SRM: Primary systemic amyloidosis; involvement of cardiac valves, joints and bones, with pathologic fracture of femur, Arch. Path. 27: 267-288, 1939. Google Scholar5. Hass G: Studies of amyloid; isolation of polysaccharide from amyloid-bearing tissues, Arch. Path. 34: 92-105, 1942. Google Scholar6. Larsen RM: Pathological study of primary myocardial amyloidosis, Am. J. Path. 6: 147-160, 1930. MedlineGoogle Scholar7. Peters JT: Epicellular and pericellular depositions of amyloid as starting point of amyloidosis, Arch. Path. 35: 832-835, 1943. Google Scholar8. Kuczynski MH: Edwin Goldmanns Untersuchungen über celluläre Vorgänge in Gefolge des Verdauungsprozesses auf Grund nachgelassener Präparate dargestellt und durch neue Versuche ergänzt, Virchows Arch. f. path. Anat. 239: 185-302, 1922. CrossrefGoogle Scholar9. Jaffe RH: Amyloidosis produced by injections of proteins, Arch. Path. 1: 25-36, 1926. Google Scholar10. Letterer E: Some new aspects of experimental amyloidosis, J. Path. and Bact. 61: 496-498, 1949. Google Scholar11. Lewis PA: Hemorrhagic hepatitis in antitoxin horses, J. Med. Research 15: 449-451, 1906. Google Scholar12. Smetana H: Relation of reticulo-endothelial system to formation of amyloid, J. Exper. Med. 45: 619-632, 1927. CrossrefMedlineGoogle Scholar13. Magnus-Levy A: Multiple myeloma; Euglobulinämie, zur Klinik and Pathologie—Amyloidosis, Ztschr. f. klin. Med. 126: 62-111, 1933. Google Scholar14. Teilum G: Allergic hyperglobulinosis and hyalinosis (paramyloidosis) in reticulo-endothelial system in Boeck's sarcoid and other conditioning morphologic immunity reaction, Am. J. Path. 24: 389-407, 1948. MedlineGoogle Scholar15. Richter GW: The reabsorption of amyloid under experimental conditions, Am. J. Path. 30: 239-261, 1954. MedlineGoogle Scholar16. AltshulerAngevine CHDM: Histochemical studies on pathogenesis of fibrinoid, Am. J. Path. 25: 1061-1077, 1949. MedlineGoogle Scholar17. Graham W: Primary amyloidosis simulating cirrhosis of liver, Canad. M. A. J. 66: 58-61, 1952. MedlineGoogle Scholar18. JacksonSlavin AM: Primary amyloidosis; report of two cases, Am. Heart J. 47: 839-844, 1954. CrossrefMedlineGoogle Scholar19. Latvalahti J: Experimental studies on the influence of certain hormones on the development of amyloidosis, Acta endocrinol. Suppl. 16: 1-89, 1953. Google Scholar20. Teilum G: Cortisone-ascorbic acid interaction and pathogenesis of amyloidosis; mechanism of action of cortisone on mesenchymal tissue, Ann. Rheumat. Dis. 11: 119-135, 1952. CrossrefMedlineGoogle Scholar21. Shuttleworth J: In process of publication. Google Scholar22. Weisbrod FG: Serum polysaccharide in cancer, J. Lab. and Clin. Med. 35: 408-410, 1950. Google Scholar23. WinzlerDevorMehlSmyth RJAWJWIM: Studies on mucoproteins of human plasma; determination and isolation, J. Clin. Investigation 27: 609-616, 1948. CrossrefGoogle Scholar24. HopkinsBlackRoss RSHSH: Xanthelasma and leprosy, Arch. Dermat. and Syph. 39: 239-252, 1939. CrossrefGoogle Scholar25. RossGemar SHF: Studies on serum proteins in leprosy; the alpha, beta and gamma globulin fractions, Internat. J. Leprosy 19: 445-452, 1951. MedlineGoogle Scholar26. Ross H: Thymol turbidity and cephalin cholesterol tests, euglobulin, albumin-globulin ratio and serology in leprosy, Internat. J. Leprosy 17: 237-245, 1949. MedlineGoogle Scholar27. SeibertSeibertAtnoCampbell FBMVAJHW: Variation in protein and polysaccharide content of sera in chronic diseases, tuberculosis, sarcoidosis and carcinoma, J. Clin. Investigation 26: 90-102, 1947. CrossrefGoogle Scholar28. Meyer K: Biological significance of hyaluronic acid and hyaluronidase, Physiol. Rev. 27: 335-359, 1947. CrossrefMedlineGoogle Scholar29. GrayzelJacobi HGM: Secondary amyloidosis; results of therapy with desiccated whole liver powder, Ann. Int. Med. 12: 39-58, 1938. LinkGoogle Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: Carville, Louisiana*Received for publication November 26, 1955.Requests for reprints should be addressed to John S. Shuttleworth, M.D., U.S.P.H.S. Hospital, Carville, Louisiana.†Chief of Medical Service, U. S. Public Health Service Hospital (National Leprosarium), Carville, Louisiana.‡Biochemist, U. S. Public Health Service Hospital, Carville, Louisiana. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byTumor-Like Lesions of the Hepatobiliary Tract Caused by Mycobacterial Infections: Tuberculosis and LepraTumor-Like Lesions of the Hepatobiliary Tract Caused by Mycobacterial Infections: Tuberculosis and LepraBrain involvement by leprosy presenting as a frontal cystic lesionAcute kidney injury in visceral leishmaniasis: a cohort of 10 patients admitted to a specialized intensive care unit in northeast of BrazilCutaneous Amyloidosis: A Concept ReviewLeprosyLeprosy and the peripheral nervous system: Basic and clinical aspectsVisceral leprosyEnd Stage Renal Disease in LeprosyRenal lesions in leprosy amongst north Indian patients.Hepatic structure and function in Papua New Guineans with leprosyRenal disease in a tropical environmentCase 10-1979: Liver Involvement in LeprosyRenal Complications of Infectious DiseasesAmyloid-related serum component (protein ASC) IN LEPROSY PATIENTSPathologie und Klinik der LepraAmyloidosePulp death in a patient with lepromatous leprosyAmyloidosisSecondary Amyloidosis in Lepromatous Leprosy Possible Relationships of Diet and EnvironmentRALPH C. WILLIAMS JR., M.D., EDGAR S. CATHCART, M.D., EVAN CALKINS, M.D., GEORGE L. FITE, M.D., JOSÉ BARBA RUBIO, M.D., ALAN S. COHEN, M.D.RENAL AMYLOIDOSIS*ROBERT D. LINDEMAN, M.D., ROBERT L. SCHEER, M.D., LAWRENCE G. RAISZ, M.D.MALABSORPTION SYNDROME DUE TO AMYLOIDOSIS OF THE INTESTINE SECONDARY TO LEPROMATOUS LEPROSY: REPORT OF A CASE*R. M. BEDDOW, M.D., I. L. TILDEN, M.D.Erkrankungen des Endokard 1 July 1956Volume 45, Issue 1Page: 23-38KeywordsAmyloid proteinsAmyloidosisAnemiaAntigensHyperglobulinemiaLeprosyMedical servicesProteinuria ePublished: 1 December 2008 Issue Published: 1 July 1956 PDF downloadLoading ...